{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:29:04Z","timestamp":1761290944421},"reference-count":108,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.dld.2010.06.005","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T08:59:08Z","timestamp":1281603548000},"page":"831-838","source":"Crossref","is-referenced-by-count":28,"title":["Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO)"],"prefix":"10.1016","volume":"42","author":[{"given":"Domenico","family":"Alvaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Cannizzaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Labianca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Valvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Farinati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2010.06.005_bib0005","series-title":"Manual for assessing health practices and designing practice guidelines","author":"Eddy","year":"1996"},{"key":"10.1016\/j.dld.2010.06.005_bib0010","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2003.11.030","article-title":"Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?","volume":"40","author":"Shaib","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.06.005_bib0015","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2004.07.035","article-title":"An increasing incidence of cholangiocarcinoma: why?","volume":"127","author":"Blendis","year":"2004","journal-title":"Gastroenterology."},{"key":"10.1016\/j.dld.2010.06.005_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2004-828889","article-title":"The epidemiology of cholangiocarcinoma","volume":"24","author":"Shaib","year":"2004","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.dld.2010.06.005_bib0025","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States","volume":"33","author":"Patel","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.06.005_bib0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2407-2-10","article-title":"Worldwide trends in mortality from biliary tract malignancies","volume":"2","author":"Patel","year":"2002","journal-title":"BMC Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0035","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/sj.bjc.6603127","article-title":"Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971\u20132001","volume":"94","author":"West","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0040","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1478-3231.2006.01350.x","article-title":"Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States","volume":"26","author":"McLean","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2010.06.005_bib0045","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/hep.510280404","article-title":"Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark","volume":"28","author":"Sorensen","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.06.005_bib0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.06.005_bib0055","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jnci\/djk201","article-title":"Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002","volume":"99","author":"Jepsen","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.dld.2010.06.005_bib0060","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jnci\/djj234","article-title":"Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States","volume":"98","author":"Welzel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.dld.2010.06.005_bib0065","unstructured":"Commissione AISF 2009. Il Colangiocarcinoma. Web site: webaisf.com."},{"key":"10.1016\/j.dld.2010.06.005_bib0070","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","article-title":"Cholangiocarcinoma","volume":"366","author":"Khan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2010.06.005_bib0075","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/hep.22310","article-title":"Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment","volume":"48","author":"Blechacz","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.06.005_bib0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.510300101","article-title":"Primary sclerosing cholangitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.06.005_bib0085","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2010.06.005_bib0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.06.005_bib0095","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.06.005_bib0100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ije\/25.5.933","article-title":"Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea","volume":"25","author":"Shin","year":"1996","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.dld.2010.06.005_bib0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00535-003-1249-x","article-title":"Cholangiocarcinoma coincident with schistosomiasis japonica","volume":"39","author":"Andoh","year":"2004","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2010.06.005_bib0110","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.21146","article-title":"Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand","volume":"117","author":"Honjo","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0115","first-page":"911","article-title":"Cholangiocarcinoma associated with thorium dioxide (thorotrast): report of a case","volume":"70","author":"Rota","year":"1971","journal-title":"Mich Med"},{"key":"10.1016\/j.dld.2010.06.005_bib0120","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/1097-0142(19880915)62:6<1153::AID-CNCR2820620619>3.0.CO;2-I","article-title":"Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma","volume":"62","author":"Ito","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0125","first-page":"1","volume":"526","author":"National Toxicology Program","year":"2006","journal-title":"Natl Toxicol Program Tech Rep Ser"},{"key":"10.1016\/j.dld.2010.06.005_bib0130","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/bjs.1800750826","article-title":"Choledochal cyst: a 33-year review","volume":"75","author":"Robertson","year":"1988","journal-title":"Br J Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0135","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1053\/jpsu.2002.36186","article-title":"Choledochal cysts: age of presentation, symptoms, and late complications related to Todani's classification","volume":"37","author":"De Vries","year":"2002","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0140","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1445-2197.1991.tb00172.x","article-title":"Cholangiocarcinoma in a type III choledochal cyst","volume":"61","author":"Pisano","year":"1991","journal-title":"Aust N Z J Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0145","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/archsurg.1983.01390080088022","article-title":"Carcinoma in choledochal cysts. Age-related incidence","volume":"118","author":"Voyles","year":"1983","journal-title":"Arch Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0150","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/bjs.1800840717","article-title":"Hepatolithiasis associated with cholangiocarcinoma","volume":"84","author":"Su","year":"1997","journal-title":"Br J Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10552-007-9067-8","article-title":"Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification","volume":"19","author":"Ishiguro","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.dld.2010.06.005_bib0160","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/sj.bjc.6604047","article-title":"Gallstones and the risk of biliary tract cancer: a population-based study in China","volume":"97","author":"Hsing","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/08998280.2000.11927636","article-title":"Association of an abnormal pancreaticobiliary junction with biliary tract cancers","volume":"13","author":"Roukounakis","year":"2000","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.dld.2010.06.005_bib0170","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00432-006-0125-5","article-title":"Lysophosphatidylcholine suppresses apoptotic cell death by inducing cyclooxygenase-2 expression via a Raf-1 dependent mechanism in human cholangiocytes","volume":"132","author":"Gwak","year":"2006","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.dld.2010.06.005_bib0175","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2002-23632","article-title":"Long-term follow-up of patients after endoscopic sphincterotomy for choledocholithiasis, and risk factors for recurrence","volume":"34","author":"Costamagna","year":"2002","journal-title":"Endoscopy"},{"key":"10.1016\/j.dld.2010.06.005_bib0180","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.cgh.2008.04.016","article-title":"Endoscopic sphincterotomy and risk of malignancy in the bile ducts, liver, and pancreas","volume":"6","author":"Str\u00f6mberg","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.06.005_bib0185","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jnci\/djn102","article-title":"Endoscopic sphincterotomy and long-term risk of cholangiocarcinoma: a population-based follow-up study","volume":"100","author":"Mortensen","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.dld.2010.06.005_bib0190","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1023\/A:1013747228572","article-title":"Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case\u2013control study in Italy","volume":"12","author":"Donato","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.dld.2010.06.005_bib0195","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1349-7006.2004.tb02492.x","article-title":"Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma","volume":"95","author":"Yamamoto","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1016\/j.dld.2010.06.005_bib0200","first-page":"1138","article-title":"Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients","volume":"113","author":"Lu","year":"2000","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.dld.2010.06.005_bib0205","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T","article-title":"Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis","volume":"88","author":"Kobayashi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0210","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.humpath.2006.04.012","article-title":"Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States","volume":"37","author":"Perumal","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.dld.2010.06.005_bib0215","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study","volume":"5","author":"Welzel","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.06.005_bib0220","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/01.meg.0000243876.79325.a1","article-title":"Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study","volume":"19","author":"Ahrens","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.06.005_bib0225","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0002-9343(65)90178-6","article-title":"Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features","volume":"38","author":"Klatskin","year":"1965","journal-title":"Am J Med"},{"key":"10.1016\/j.dld.2010.06.005_bib0230","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jamcollsurg.2008.09.007","article-title":"Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature","volume":"208","author":"Aljiffry","year":"2009","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0235","first-page":"170","article-title":"Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver","volume":"140","author":"Bismuth","year":"1975","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.dld.2010.06.005_bib0240","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2","article-title":"Liver, gallbladder, extrahepatic bile ducts, and pancreas","volume":"75","author":"Carriaga","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0245","first-page":"616","article-title":"The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma\u2014the influence of sampling time and hepatolithiasis","volume":"49","author":"Chen","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.dld.2010.06.005_bib0250","doi-asserted-by":"crossref","first-page":"451","DOI":"10.7326\/0003-4819-147-7-200710020-00003","article-title":"Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis","volume":"147","author":"Alvaro","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2010.06.005_bib0255","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MOG.0b013e328325a894","article-title":"Serum and bile biomarkers for cholangiocarcinoma","volume":"25","author":"Alvaro","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.dld.2010.06.005_bib0260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1572-0241.2003.04006.x","article-title":"EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology","volume":"99","author":"Fritscher-Ravens","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.06.005_bib0265","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1542-3565(04)00005-9","article-title":"Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma","volume":"2","author":"Eloubeidi","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.06.005_bib0270","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1542-3565(04)00055-2","article-title":"Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: an evidence-based approach","volume":"2","author":"Levy","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.06.005_bib0275","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.gastro.2003.07.015","article-title":"Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study","volume":"125","author":"Ortner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2010.06.005_bib0280","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1634\/theoncologist.9-1-43","article-title":"Diagnosis and treatment of cholangiocarcinoma","volume":"9","author":"Anderson","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.dld.2010.06.005_bib0285","first-page":"36","article-title":"The role of the gastroenterologist in the management of patients with digestive cancers","volume":"9","author":"Winawer","year":"2004","journal-title":"World Gastroenterology News"},{"issue":"991","key":"10.1016\/j.dld.2010.06.005_bib0290","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/pgmj.2007.066589","article-title":"Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms","volume":"84","author":"He","year":"2008","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.dld.2010.06.005_bib0295","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/PL00009949","article-title":"Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience","volume":"5","author":"Lieser","year":"1998","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0300","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00000658-199801000-00011","article-title":"Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases","volume":"227","author":"Madariaga","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0305","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s005340050094","article-title":"Resection of intrahepatic cholangiocarcinoma: a Western experience","volume":"6","author":"Valverde","year":"1999","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0310","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s11605-007-0282-0","article-title":"Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis","volume":"11","author":"Nathan","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0315","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","article-title":"Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma","volume":"234","author":"Jarnagin","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0320","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/00007890-200004270-00019","article-title":"Liver transplantation for cholangiocarcinoma: results in 207 patients","volume":"69","author":"Meyer","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2010.06.005_bib0325","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma","volume":"242","author":"Rea","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0330","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00000658-199911000-00008","article-title":"Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection","volume":"230","author":"Kosuge","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0335","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1072-7515(98)00207-5","article-title":"Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation","volume":"187","author":"Iwatsuki","year":"1998","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0340","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1053\/jlts.2000.18507","article-title":"Changing strategies in diagnosis and management of hilar cholangiocarcinoma","volume":"6","author":"Figueras","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2010.06.005_bib0345","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00001813-199806000-00004","article-title":"Weekly 24h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas","volume":"9","author":"Chen","year":"1998","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.dld.2010.06.005_bib0350","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1200\/JCO.1996.14.8.2311","article-title":"Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer","volume":"14","author":"Patt","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2010.06.005_bib0355","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/0959-8049(95)00323-B","article-title":"Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours","volume":"31A","author":"Ellis","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0360","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/cncr.20368","article-title":"Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma","volume":"101","author":"Patt","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0365","first-page":"783","article-title":"Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas","volume":"48","author":"Kubicka","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.dld.2010.06.005_bib0370","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/cncr.21741","article-title":"A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer","volume":"106","author":"Kim","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0375","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/cncr.22902","article-title":"Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer","volume":"110","author":"Riechelmann","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0380","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/A:1016209901417","article-title":"Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas","volume":"20","author":"Kuhn","year":"2002","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.dld.2010.06.005_bib0385","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1440-1746.2006.04230.x","article-title":"Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer","volume":"21","author":"Park","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.06.005_bib0390","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00000421-200304000-00010","article-title":"Phase II trial of the use of gemcitabine and 5-fluorouracil in the treatment of advanced pancreatic and biliary tract cancer","volume":"26","author":"Murad","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.dld.2010.06.005_bib0395","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/annonc\/mdh351","article-title":"Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study","volume":"15","author":"Andr\u00e9","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2010.06.005_bib0400","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1200\/JCO.2005.51.008","article-title":"Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial","volume":"23","author":"Knox","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2010.06.005_bib0405","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/sj.bjc.6603648","article-title":"Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials","volume":"26","author":"Eckel","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0410","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/jjco\/hym116","article-title":"A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer","volume":"37","author":"Yonemoto","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.dld.2010.06.005_bib0415","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bjc.6605211","article-title":"Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study\u2014The UK ABC-01 Study","volume":"101","author":"Valle","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0420","doi-asserted-by":"crossref","DOI":"10.1007\/s00280-009-1115-5","article-title":"Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy","author":"Sasaki","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"issue":"42","key":"10.1016\/j.dld.2010.06.005_bib0425","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.3748\/wjg.15.5279","article-title":"Comorbidity negatively influences prognosis in patients with extrahepatic cholangiocarcinoma","volume":"15","author":"Fern\u00e1ndez-Ruiz","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2010.06.005_bib0430","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/hep.23214","article-title":"Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2","volume":"50","author":"Blechacz","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.06.005_bib0435","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.bjc.6605458","article-title":"Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial","volume":"102","author":"Bengala","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0440","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<26::AID-CNCR5>3.0.CO;2-K","article-title":"What constitutes long term survival after surgery for hilar cholangiocarcinoma?","volume":"79","author":"Klempnauer","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0445","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1365-2168.2000.01343.x","article-title":"Radical resection of hilar bile duct carcinoma and predictors of survival [In Process Citation]","volume":"87","author":"Todoroki","year":"2000","journal-title":"Br J Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0450","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/cncr.11699","article-title":"Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implication for adjuvant therapeutic strategies","volume":"98","author":"Jarnagin","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0455","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0360-3016(03)00770-3","article-title":"Intraluminal low-dose rate 192 Ir brachiterapy combined with external beam radiotherapy and biliary stenting for unresectable extraepatic bile duct carcinoma","volume":"57","author":"Takamura","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.dld.2010.06.005_bib0460","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3748\/wjg.v12.i2.331","article-title":"Treatment of malignant biliary obstruction by combined percutaneus transhepatic biliary drainage with local tumor treatment","volume":"12","author":"Qian","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2010.06.005_bib0465","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0360-3016(93)90423-S","article-title":"Definitive postoperative irradiation of bile duct carcinoma with charged particles and\/or photons","volume":"27","author":"Schoenthaler","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.dld.2010.06.005_bib0470","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00130404-200201000-00013","article-title":"High dose rate remote after loading intracavitary brachiterapy for the treatment of extrahepatic biliary duct carcinoma","volume":"8","author":"Lu","year":"2002","journal-title":"Cancer J"},{"key":"10.1016\/j.dld.2010.06.005_bib0475","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0360-3016(94)90115-5","article-title":"The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer","volume":"28","author":"Alden","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.dld.2010.06.005_bib0480","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0360-3016(99)00472-1","article-title":"Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma [see comments]","volume":"46","author":"Todoroki","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.dld.2010.06.005_bib0485","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0360-3016(97)00299-X","article-title":"External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma","volume":"39","author":"Foo","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.dld.2010.06.005_bib0490","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-2008-1040466","article-title":"Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor)","volume":"10","author":"Gonzalez Gonzalez","year":"1990","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2010.06.005_bib0495","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijrobp.2008.09.017","article-title":"Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas","volume":"74","author":"Shinohara","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.dld.2010.06.005_bib0500","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejso.2006.09.033","article-title":"Predictive factors for prognosis of hilar cholangiocarcinoma: postresection radiotherapy improves survival","volume":"33","author":"Cheng","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.dld.2010.06.005_bib0505","first-page":"63","article-title":"Preoperative irradiation of biliary tract malignancy","volume":"41","author":"Sunakawa","year":"1994","journal-title":"Jikei Med J"},{"key":"10.1016\/j.dld.2010.06.005_bib0510","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9610(97)00203-1","article-title":"Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma","volume":"174","author":"McMasters","year":"1997","journal-title":"Am J Surg"},{"key":"10.1016\/j.dld.2010.06.005_bib0515","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijrobp.2008.07.008","article-title":"Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma","volume":"73","author":"Nelson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.dld.2010.06.005_bib0520","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/1097-0142(19911101)68:9<2051::AID-CNCR2820680934>3.0.CO;2-M","article-title":"Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma","volume":"68","author":"Altaee","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2010.06.005_bib0525","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/00000658-199611000-00007","article-title":"Surgical treatment in proximal bile duct cancer. A single-center experience","volume":"224","author":"Pichlmayr","year":"1996","journal-title":"Ann Surg"},{"issue":"Suppl. 4","key":"10.1016\/j.dld.2010.06.005_bib0530","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1008301522956","article-title":"Future role of radiotherapy as a component of treatment in biliopancreatic cancers","volume":"10","author":"Gunderson","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2010.06.005_bib0535","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.soc.2008.12.008","article-title":"Transplantation for Cholangiocarcinoma: When and Whom?","volume":"18","author":"Rea","year":"2009","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.dld.2010.06.005_bib0540","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.3748\/wjg.15.4240","article-title":"Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990\u20132009","volume":"15","author":"Aljiffry","year":"2009","journal-title":"World J Gastroenterol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865810002112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865810002112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T23:17:48Z","timestamp":1636067868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865810002112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":108,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1590865810002112"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2010.06.005","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}